ASSESSMENT OF PRESCRIPTION TRENDS, QUALITY OF LIFE, AND ADVERSE DRUG REACTIONS IN MIGRAINE MANAGEMENT: A CROSS-SECTIONAL STUDY AT A TERTIARY CARE TEACHING HOSPITAL
Main Article Content
Keywords
Migraine, Migraine Treatment, Quality of life, Migraine specific Quality of life, ADR
Abstract
Objective: To assess the prescription patterns in migraine patients, evaluate the impact of migraine on their quality of life, and identify and report any adverse drug reactions (ADRs).
Background: Migraine is a common neurological illness characterized by the release of inflammatory chemicals in the brain, leading to pain in the cranial area. It predominantly affects individuals between the ages of 35 and 45, with a higher incidence among females. Various symptoms, such as nausea, vomiting, and sensitivity to light and sound, are observed in migraine patients. The exact cause of migraines is unknown, but factors like genetic predisposition, hormonal influences, and lifestyle triggers play a role.
Methodology: A cross-sectional observational study was conducted at Parul Sevashram Hospital over a 10 months. In this study patients were enrolled form the inpatients and outpatient department of neurology to assess the prescription patterns, quality of life, and adverse drug reactions (ADRs) among migraine patients. Data was collected from patients' case sheets and prescriptions. The HIT-6 scale and Migraine Specific Quality of Life (MSQoL) Questionnaire were used to evaluate quality of life, and ADRs were recorded using the CDSCO reporting form.
Results: A total of 153 patients with migraine were included in the study, with a higher The age group of 26-40 years had the highest number of migraine patients (41%). Naproxen and Domperidone were the most frequently prescribed drugs, accounting for 86.27% of all prescriptions, followed closely by Flunarizine (54.90%) in preventive treatment.
Conclusion: This study highlights the higher prevalence of migraines among females, emphasizing the need for gender-specific management strategies. Common prescriptions include naproxen, domperidone, and flunarizine, with NSAIDs and antiemetics prevailing. Quality of life assessments show moderate scores, varying by age, gender, and pain intensity, with males reporting higher scores in certain domains, suggesting gender-specific coping mechanisms. The findings underscore the complexity of migraine management and advocate for personalized approaches tailored to individual patient needs.
References
2. Kulkarni GB, Rao GN, Gururaj G, Stovner LJ, Steiner TJ. Headache disorders and public ill-health in India: prevalence estimates in Karnataka State. The journal of headache and pain. 2015 Dec;16:1-7.
3. Steiner, T.J., Stovner, L.J. Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19, 109–117 (2023).
4. How does migraine disease impact quality of life? (2022, May 1). Migraine.com. https://migraine.com/living-with-migraine/migraine-and-quality-of-life
5. Takaki, H., Onozuka, D., & Hagihara, A. (2018). Migraine-preventive prescription patterns by physician specialty in ambulatory care settings in the United States. Preventive Medicine Reports, 9, 62–67. https://doi.org/10.1016/j.pmedr.2017.12.009
6. Lew C, Punnapuzha S. Migraine Medications. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553159/
7. Hadia, R., Kapadi, V., Parekh, K., Naidu, S., Prakash, S., Chandrakar, V., & Rajput, H. S. (2022). A cross sectional observational study to assess clinical characteristics, prescription pattern and health related quality of life in migraine patients at tertiary care teaching hospital. Journal of Young Pharmacists: JYP, 14(3), 314–321.
8. Bhave K, Tondare S, Pandit P, Patankar R. Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: An observational study. National Journal of Physiology, Pharmacy and Pharmacology. 2022;12(11):1939-1943.
9. Singh, S., Sarda, K., & Hegde, R. (2017). A pan-India study to assess the quality of life, symptom profile and management trends in patients with migraine: A cross-sectional study. The Journal of the Association of Physicians of India, 65(12), 63–69.
10. Almosaiteer SA, Rabbani U, Alharbi BA, Aldukhayel A. Quality of life and its predictors among patients with migraine in Qassim region, Saudi Arabia: a cross-sectional study. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2022 Jun 3;58-65.
11. Jena SS, Jena M, Dash M, Mishra S, Behera IC. Migraine: Pattern of Prescription & Adverse Drug Reaction Profile in A Tertiary Care Teaching Hospital. Journal of Pharmaceutical Sciences and Research. 2015 Mar 1;7(3):111-116
12. Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia [Internet]. 2011;31(3):301–315. Available from: https://pubmed.ncbi.nlm.nih.gov/20813784/
13. Soni G, Jain S, Rathi P, Goswami P. CURRENT TRENDS IN PRESCRIBING PATTERN OF ANTI-MIGRAINE DRUGS IN PATIENTS OF MIGRAINE AT A TERTIARY CARE TEACHING HOSPITAL. International Journal of Medicine and Medical Research. 2021;7(2):5-14.
14. Machado-Duque ME, Gaviria-Mendoza A, Machado-Alba JE. Prescription patterns of antimigraine drugs. Revista Ecuatoriana de Neurología. 2021 Jul;30(1):50-56.
15. Speck RM, Shalhoub H, Wyrwich KW, Yu R, Ayer DW, Ford J, Bush EN, Lipton RB. Psychometric validation of the role function restrictive domain of the Migraine Specific Quality‐of‐Life questionnaire Version 2.1 electronic patient‐reported outcome in patients with episodic and chronic migraine. Headache: The Journal of Head and Face Pain. 2019 May;59(5):756-774.